More on VTVT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $32.79 |
|
|||
| Open | $32.99 | ||||
| 52 Wk High | $7.70 | ||||
| 52 Wk Low | $4.69 | ||||
| Day High | $33.80 | ||||
| Day Low | $32.97 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 8,492 | ||||
- vTv Therapeutics to Participate in September Investor Conferences
- vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Form 10-Q vTv Therapeutics Inc. For: Jun 30
- Form 8-K vTv Therapeutics Inc. For: Aug 06
- vTv Therapeutics (VTVT) Misses Q2 EPS by 15c
- vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- Form SCHEDULE 13G/A vTv Therapeutics Inc. Filed by: MILLENNIUM MANAGEMENT LLC
- vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Rodman & Renshaw Starts vTv Therapeutics (VTVT) at Buy
Entities mentioned with VTVT
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13D | View Related Stories »
- Twitter | View Related Stories »
- S1 | View Related Stories »
- Pre Market Movers | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
